Legal Representation
Attorney
Alexandra T. MacKay
USPTO Deadlines 1 active
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
MAINTENANCE
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-11-20) |
R.PRA | Nov 20, 2027 | 866 days | Critical | No |
Next deadline: Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-11-20)
on November 20, 2027
(866 days)
Application History
42 eventsDate | Code | Type | Description |
---|---|---|---|
Nov 27, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Nov 27, 2017 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
Nov 27, 2017 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
Nov 27, 2017 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
Oct 30, 2017 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Nov 20, 2016 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Jan 24, 2013 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Jan 24, 2013 | 15AK | O | REGISTERED - SEC. 15 ACKNOWLEDGED |
Jan 24, 2013 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
Jan 24, 2013 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
Jan 24, 2013 | NA15 | E | SEC. 15 ACKNOWLEDGEMENT - E-MAILED |
Jan 15, 2013 | ES8R | I | TEAS SECTION 8 RECEIVED |
Jan 15, 2013 | E15R | I | TEAS SECTION 15 RECEIVED |
Jul 13, 2009 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jul 13, 2009 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Nov 20, 2007 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Sep 4, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION |
Aug 15, 2007 | NPUB | O | NOTICE OF PUBLICATION |
May 24, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
May 23, 2007 | CNEA | O | EXAMINERS AMENDMENT MAILED |
May 22, 2007 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
May 22, 2007 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
May 22, 2007 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 20, 2007 | CNFR | O | FINAL REFUSAL MAILED |
Mar 19, 2007 | CNFR | R | FINAL REFUSAL WRITTEN |
Feb 27, 2007 | ALIE | A | ASSIGNED TO LIE |
Feb 27, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 27, 2007 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
Jan 29, 2007 | I | PAPER RECEIVED | |
Oct 12, 2006 | FAXX | O | FAX SENT |
Sep 12, 2006 | CNRT | O | NON-FINAL ACTION MAILED |
Sep 11, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN |
Sep 8, 2006 | UNDN | O | UNDELIVERABLE MAIL - NO ACTION TAKEN |
Aug 16, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
Jul 31, 2006 | CNRT | F | NON-FINAL ACTION MAILED |
Jul 29, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jul 28, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
Jul 20, 2006 | UNPR | I | UNRESPONSIVE/DUPLICATE PAPER RECEIVED |
Jul 20, 2006 | UNPR | I | UNRESPONSIVE/DUPLICATE PAPER RECEIVED |
Jun 16, 2006 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
May 5, 2006 | I | PAPER RECEIVED | |
Feb 14, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 001
Biochemicals for use in the manufacture of pharmaceutical [ and veterinary ] preparations
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
(( Pharmaceuticals and biochemical preparations for the treatment of bone, cartilage and joint diseases, in particular osteoporosis, osteoarthritis and rheumatoid arthritis, and for the treatment of inflammation and immune diseases, proliferative and metastatic diseases, and metabolic diseases ))
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific research services in the medical and biochemical fields, namely, the examination and testing of genes as part of research and discovery procedures; development, examination and testing of pharmaceutical and biochemical semi-finished products, especially for use in medicaments; development, examination and testing of medicaments; development of test systems for pharmaceutical and biochemical products [, veterinary and hygienic products for medical use, and dietetic substances for medical use ]; development of database in the medical and biochemical field and development of genes banks
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042